Abraham et al.
Pivotal randomized prospective trial including 550 patients. Results showed a 33% annualized reduction in HFH regardless of ejection fraction.1
Adamson et al.
A CHAMPION trial subgroup analysis of 119 patients with preserved ejection fraction (>= 40%). At 6 months, heart failure hospitalizations were 46% lower in the treatment cohort when compared with the control. This is the first study to demonstrate the CardioMEMS HF System as the ONLY proven solution for HFpEF patients.2
Study | N | Reduce HFH | Reduce PAP | Increase Survival | HFpEF Benefit | Increase QoL | Safety | Adherence | Med changes |
---|---|---|---|---|---|---|---|---|---|
CHAMPION Pivotal Study 2016. Pivotal, Prospective Study - Abraham | N=550 | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | ||
Real-world Study 2017. Retrospective - Heywood | N=2000 | ✓ | ✓ | ✓ | |||||
Economic Impact 2017. Retrospective - Desai | N=1114 | ✓ | |||||||
Optimizing GDMT 2017. Retrospective, CHAMPION Subgroup - Givertz | N-=456 | ✓ | ✓ | ✓ | |||||
Propensity-Matched Cohort 2019. Retrospective - J. Abraham | N=2174 | ✓ | ✓ | ||||||
US Post-Approval Study 2020. Prospective - Shavelle | N=1200 | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | |
MEMS-HF 2019. Prospective, multi-center, EU - Angermann | N=234 | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | |
Proven Management in HFpEF Patients - Adamson | N=119 | ✓ | ✓ | ✓ |
* Unpublished
MAT-2006905 v2.0
Unless otherwise specified, all product and service names appearing in this Internet site are trademarks owned by or licensed to Abbott, its subsidiaries or affiliates. No use of any Abbott trademark, trade name, or trade dress in this site may be made without the prior written authorization of Abbott, except to identify the product or services of the company.
Unless otherwise specified, all product and service names appearing in this Internet site are trademarks owned by or licensed to Abbott, its subsidiaries or affiliates. No use of any Abbott trademark, trade name, or trade dress in this site may be made without the prior written authorization of Abbott, except to identify the product or services of the company.
Precautions
Please be sure to read it.
The following pages are intended for medical professionals and provide information on the proper use of products (medical devices, etc.) of Abbott Medical Japan GK.
The information provided here is not intended to provide information to patients and the general public.
Are you a healthcare professional?
Test